PHGDH and Parkinson disease: To bridge these findings to clinical applications, a heterogeneous information network (HIN) learning model integrating multi-omics data (e.g., metabolomics, proteomics, and mitochondrial genomics) could map PD-specific CCM bottlenecks (e.g., malate dehydrogenase dysfunction) to prioritize therapeutic targets (64).